VIA PHARMACEUTICALS
VIA Pharmaceuticals is a biotechnology company focused on the treatment of cardiovascular disease.VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need รขโฌโ reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke.
VIA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2004-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.viapharmaceuticals.com
Total Employee:
1+
Status:
Active
Total Funding:
13.2 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Ajax Vascular
Ajax Vascular is a biotechnology company that focuses on cardiovascular devices.
Amathus Therapeutics
Amathus Therapeutics is a biotechnology company that develops small molecules to treat stress and Parkinsonโs disease.
CardioFocus
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Ovalis
Ovalis is a biotechnology company that develops catheter-based medical devices for the repair of cardiovascular defects.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
RevMAb Biosciences
RevMAb Biosciences is biotechnology company that focuses on the developing of goat and rabbit monoclonal antibodies.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Suvica
Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer.
Vascular Imaging
Vascular Imaging is a biotechnology company engaged in the development of medical devices.
Founder
Investors List
Bay City Capital
Bay City Capital investment in Debt Financing - VIA Pharmaceuticals
Official Site Inspections
http://www.viapharmaceuticals.com
Unable to get host informations!!!
More informations about "VIA Pharmaceuticals"
VIA Pharmaceuticals - Crunchbase Company Profile & Funding
VIA Pharmaceuticals is a biotechnology company focused on the development of small-molecule drugs to treat cardiovascular diseases.See details»
Via Pharmaceuticals - PitchBook
Information on stock, financials, earnings, subsidiaries, investors, and executives for Via Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
VIA Pharmaceuticals Inc - Company Profile and News
VIA Pharmaceuticals Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. The Company is developing a pipeline of small โฆSee details»
VIA Pharmaceuticals - Products, Competitors, Financials, โฆ
VIA Pharmaceuticals provides drug development that targets vascular inflammation. Using proprietary drug assessment tools, the company has established a screening system to โฆSee details»
Via Pharmaceuticals Inc (VIAP) Profile - The Globe and Mail
See the company profile for Via Pharmaceuticals Inc (VIAP) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
VIA Pharmaceuticals - VentureRadar
Website: http://www.viapharmaceuticals.com/ Similar Companies: Evolva Switzerland Publicly Traded Evolva solves the supply chain issues of nature through a 21st century mix of โฆSee details»
VIA Pharmaceuticals Inc. - MarketWatch
VIA Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of compounds for the treatment of cardiovascular diseases. It builds a pipeline of small molecule โฆSee details»
VIA Pharmaceuticals Licenses Drug Candidates from Roche to โฆ
SAN FRANCISCO, Dec. 23 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of โฆSee details»
VIA Pharmaceuticals, Inc. | Insights
Dec 6, 2018ย ยท Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Via Pharmaceuticals-Via Pharmaceuticals Inc.-ไผไธ่ฏฆๆ
Dec 31, 2003ย ยท VIA Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of compounds for the treatment of cardiovascular diseases. It builds a pipeline of โฆSee details»
VIA Pharmaceuticals, Inc. (VIAP) - Yahoo Finance
VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases.See details»
VIA Pharmaceuticals (VIAP) Stock Price, News & Analysis
6 days agoย ยท VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases.See details»
VIA Pharmaceuticals CEO, Founder, Key Executive Team, Board of ...
VIA Pharmaceuticals has 2 board of directors, including David Howard. Fred Craves, PhD, is the Founder of Bay City Capital. Since launching the firm in 1997, Fred has built Bay City Capital โฆSee details»
VIA Pharmaceuticals Inc (VIAP) Stock Price & News - Google
Get the latest VIA Pharmaceuticals Inc (VIAP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.See details»
VIA Pharmaceuticals, Inc. Licenses Drug Candidates from
Dec 23, 2008ย ยท In addition, VIAโs pipeline of drug candidates includes other compounds to address other underlying causes of cardiovascular disease: high cholesterol, diabetes and โฆSee details»
VIAP: VIA Pharmaceuticals Inc Stock Price Quote - Bloomberg
Stock analysis for VIA Pharmaceuticals Inc (VIAP:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.See details»
Via Pharmaceuticals Inc (VIAP) Stock Price, Quote, News & History
Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at...See details»
VIA Pharmaceuticals Announces Strategic Restructuring and โฆ
Apr 1, 2010ย ยท VIA Pharmaceuticals Announces Strategic Restructuring and Financing. Financing, Workforce Reduction Aimed at Focusing Resources on Research and Development Related to โฆSee details»
VIA Pharmaceuticals Inc. (VIAP) Stock Price Today - WSJ
View the latest VIA Pharmaceuticals Inc. (VIAP) stock price, news, historical charts, analyst ratings and financial information from WSJ.See details»
VIA Pharmaceuticals Announces First-In-Human Dosing Of VIA โฆ
Jun 14, 2011ย ยท As a beta-selective THR agonist, VIA-3196 is designed to specifically target receptors in the liver involved in metabolism and cholesterol regulation, and avoid side effects โฆSee details»